TSE:CRON Cronos Group - CRON Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$2.67 +0.05 (+1.91%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's RangeC$2.59▼C$2.6750-Day RangeC$2.57▼C$3.4352-Week RangeC$2.53▼C$5.36Volume163,912 shsAverage Volume300,364 shsMarket CapitalizationC$1.02 billionP/E RatioN/ADividend YieldN/APrice TargetC$4.71 ProfileAnalyst RatingsChartCompetitorsHeadlinesOptions ChainSocial Media About Cronos Group (TSE:CRON) StockCronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CRON Stock News HeadlinesMarch 20, 2023 | finance.yahoo.comCronos Group Inc.'s (TSE:CRON) largest shareholders are public companies with 41% ownership, individual investors own 41%March 13, 2023 | marketwatch.comCronos Group Inc. stock rises Monday, outperforms marketMarch 26, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.March 10, 2023 | marketwatch.comCultivation and Processing of Canabis Market to 2023-2028March 1, 2023 | marketwatch.comCronos Group Inc. stock falls Wednesday, underperforms marketFebruary 28, 2023 | finance.yahoo.comCronos Group Inc.: Cronos' Earnings: Respectable Progress on Narrowing Losses but Positive EBITDA Remains Years AwayFebruary 28, 2023 | marketwatch.comCronos Group Inc. stock rises Tuesday, outperforms marketFebruary 28, 2023 | finance.yahoo.comCronos Group (CRON) Q4 2022 Earnings Call TranscriptMarch 26, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.February 28, 2023 | finance.yahoo.comTop Cannabis Stocks for March 2023February 28, 2023 | marketwatch.comCronos Group 4Q Loss Narrows, Revenue Declines in Line With ViewsFebruary 28, 2023 | markets.businessinsider.comCronos Q4 2022 Revenue Declines 11% YoY, What About Net Loss?February 27, 2023 | msn.comEarnings Preview For Cronos GroupFebruary 9, 2023 | msn.comCreate a Stream of Passive Income with These Proven Winning StocksFebruary 6, 2023 | finance.yahoo.comAltria Group, Inc.: Maintaining HOLD following 4Q resultsJanuary 26, 2023 | msn.comCDC denies bids to market CBD products as dietary supplementsJanuary 24, 2023 | marketwatch.comCronos Group Inc. stock falls Tuesday, underperforms marketDecember 19, 2022 | msn.comAltria to claim $483 mln capital loss on cannabis company ownership stakeDecember 7, 2022 | seekingalpha.comCronos Group Inc. (CRON) Stifel Canada Future of Healthcare Conference TranscriptDecember 6, 2022 | finance.yahoo.comDown 76% This Year, Is This Growth Stock Now a Screaming Buy?December 5, 2022 | finance.yahoo.comCrypto Rally Continues With Cronos, The Sandbox, and Axie Infinity Surging TodayNovember 21, 2022 | fool.comSearching for Huge Passive Income? Buy This Dividend KingNovember 18, 2022 | finance.yahoo.comCrypto Contagion Concerns Sink Cronos, Curve, and Polygon This WeekNovember 16, 2022 | msn.comCannabis Stock Movers For November 16, 2022November 7, 2022 | seekingalpha.comCronos Group Inc. (CRON) Q3 2022 Earnings Call TranscriptNovember 7, 2022 | finance.yahoo.comTop Cannabis StocksNovember 7, 2022 | markets.businessinsider.comCronos Q3 Revenue Stagnates, Remains On Track For $20M In Operating Expense SavingsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolTSE:CRON CUSIPN/A CIKN/A Webwww.thecronosgroup.com Phone416-504-0004FaxN/AEmployees626Year FoundedN/APrice Target and Rating Average Stock Price ForecastC$4.71 High Stock Price ForecastC$7.00 Low Stock Price ForecastC$3.19 Forecasted Upside/Downside+76.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth0.12Net IncomeC$-168,730,000.00 Net Margins-183.60% Pretax MarginN/A Return on Equity-13.63% Return on Assets-5.55% Debt Debt-to-Equity Ratio0.34 Current Ratio14.10 Quick Ratio24.01 Sales & Book Value Annual SalesC$91.90 million Price / Sales11.06 Cash FlowC$1.60 per share Price / Cash Flow1.67 Book ValueC$3.01 per share Price / Book0.89Miscellaneous Outstanding Shares380,580,000Free FloatN/AMarket CapC$1.02 billion OptionableOptionable Beta1.44 Key ExecutivesMr. Michael Ryan Gorenstein J.D. (Age 36)Pres, CEO & Chairman Comp: $389.15kMs. Shannon Buggy (Age 53)Sr. VP & Global Head of People Comp: $438.81kMs. Anna Shlimak (Age 37)Sr. VP of Corp. Affairs & Strategy Comp: $422.03kMr. James HolmChief Financial OfficerMr. Carlos Cortez (Age 50)VP, Controller & Principal Accounting Officer Mr. Shayne J. LaidlawDirector of Investor Relations & StrategyMr. Terry Gregory-Joseph Doucet (Age 33)Sr. VP of Legal & Regulatory Affairs and Corp. Sec. Mr. Jeffrey David Jacobson (Age 37)Chief Growth Officer Mr. Arye WeigensbergHead of R&DMr. Kevin B GiffordVP of Fin.More ExecutivesKey CompetitorsConcordia InternationalTSE:CXRBELLUS HealthTSE:BLUProMetic Life SciencesTSE:PLIFennec PharmaceuticalsTSE:FRXVIVO CannabisCVE:ABCNView All Competitors CRON Stock - Frequently Asked Questions Should I buy or sell Cronos Group stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CRON shares. View CRON analyst ratings or view top-rated stocks. What is Cronos Group's stock price forecast for 2023? 3 Wall Street analysts have issued twelve-month target prices for Cronos Group's shares. Their CRON share price forecasts range from C$3.19 to C$7.00. On average, they predict the company's stock price to reach C$4.71 in the next year. This suggests a possible upside of 76.5% from the stock's current price. View analysts price targets for CRON or view top-rated stocks among Wall Street analysts. How have CRON shares performed in 2023? Cronos Group's stock was trading at C$3.44 at the beginning of the year. Since then, CRON shares have decreased by 22.4% and is now trading at C$2.67. View the best growth stocks for 2023 here. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC). What is Cronos Group's stock symbol? Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON." How do I buy shares of Cronos Group? Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Cronos Group's stock price today? One share of CRON stock can currently be purchased for approximately C$2.67. How much money does Cronos Group make? Cronos Group (TSE:CRON) has a market capitalization of C$1.02 billion and generates C$91.90 million in revenue each year. The company earns C$-168,730,000.00 in net income (profit) each year or C($0.62) on an earnings per share basis. How many employees does Cronos Group have? The company employs 626 workers across the globe. How can I contact Cronos Group? Cronos Group's mailing address is Suite 300, Toronto, Ontario M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at 416-504-0004. This page (TSE:CRON) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.